Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01148849
Title Safety Study of MGAH22 in HER2-positive Carcinomas
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors MacroGenics
Indications

breast cancer

carcinoma

stomach cancer

Therapies

Margetuximab-cmkb

Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.